Drugs / CAR T-cells (TBC)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05991388 | May 2024 → May 2031 expected | B-cell non-Hodgkin lymphoma | University of Birmingham | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR T-cells (TBC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05991388 ↗ |
| Modality | Cell therapy | “CAR-T cell therapy - agent TBC” NCT05991388 ↗ |